| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |